Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)
Price and Volume
Detailed Quote| Volume | 20,780,813 |
| Open | 3.860 |
| Bid (Size) | 3.690 (800) |
| Ask (Size) | 3.700 (2,000) |
| Prev. Close | 3.830 |
| Today's Range | 3.650 - 4.080 |
| 52wk Range | 2.770 - 5.760 |
| Shares Outstanding | 168,425,907 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
36.1% below 52-week high
3.680
2.7752W Low
5.7652W High
1 Week
18.5% below 1-week high
3.651W Low
4.511W High
Recursion Pharmaceuticals, Inc. - Class A Common Stock (RXRX) traded between $2.77 and $5.76 over the past 52 weeks and last traded at $3.68, 36.1% below its 52-week high. Over the past week it ranged between $3.65 and $4.51.
Past 12 Months
1W
-$0.67
1M
-$1.10
3M
+$0.37
6M
+$0.31
YTD
-$0.52
1Y
-$1.76
RXRX was -32.4% over the past year, +9.2% over six months, -12.4% year to date, -15.4% in the last week.
12 Months vs Market
RXRX
-32.4%
DIA
+9.2%
SPY
+10.4%
QQQ
+8.4%
IWM
+14.0%
Over the past 12 months RXRX returned -32.4% versus DIA (Dow) +9.2%, SPY (S&P 500) +10.4%, QQQ (Nasdaq 100) +8.4% and IWM (Russell 2000) +14.0%.
Volume & Liquidity
0.93× 3-mo avg
Today 20,780,813
3-mo avg 22.3M
1W
23.4M
1M
30.6M
3M
22.3M
6M
21.6M
YTD
19.6M
1Y
20.8M
RXRX most recently traded 20,780,813 shares against a 3-month average daily volume of 22.3M.
More News
Read More
Recursion Appoints Fred Hassan as Chair of the Board
November 02, 2026
1 Big Winner and 1 Loser From the Upcoming Anthropic IPO ↗
October 31, 2026
Next-Gen Biotech: RXRX, OCGN, SNTI, VIVS, ONCO Stocks to Watch
October 28, 2026
2 Beaten-Down Stocks to Avoid Right Now ↗
September 08, 2026
The Market Just Told You Which Layer Of AI Biology It Is Paying For
September 03, 2026
Recursion (RXRX) Q2 2026 Earnings Call Transcript ↗
August 12, 2026
Recursion Pharmaceuticals Q2 Earnings Call Highlights ↗
August 05, 2026
Recursion to Participate in Upcoming Investor Conferences
August 04, 2026
3 Stocks With the Most Upside by the End of 2026 ↗
July 30, 2026
2 Beaten-Down Stocks That Still Aren't Worth Buying ↗
July 11, 2026
Frequently Asked Questions
Is Recursion Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Recursion Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Recursion Pharmaceuticals, Inc. - Class A Common Stock trade on?
Recursion Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock is RXRX on the Nasdaq Stock Market
What is the current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 3.680
When was Recursion Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Recursion Pharmaceuticals, Inc. - Class A Common Stock was at 11/03/26 04:00 PM ET
What is the market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 619.81M
How many shares of Recursion Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Recursion Pharmaceuticals, Inc. - Class A Common Stock has 620M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.